Clinical Effects and Safety of Rituximab for Treatment of Refractory Pediatric Autoimmune Diseases
Department of Medicine, Programs in Rheumatology, Gastroenterology, and Hematology and Department of Orthopaedic Surgery, Children’s Hospital Boston; and Section on Immunology and Immunogenetics, Joslin Diabetes Center; Harvard Medical School, Boston, Massachusetts
Received 16 March 2006; received in revised form 19 August 2006; accepted 19 October 2006.
PII: S0022-3476(06)01036-5
doi:10.1016/j.jpeds.2006.10.067
© 2007 Mosby, Inc. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.